Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia
J. Ung, S.-F. Tan, T. E. Fox, J. J. Shaw, M. Taori, B. J. Horton, U. Golla, A. Sharma, Z. M. Szulc, H.-G. Wang, C. E. Chalfant, M. C. Cabot, D. F. Claxton, T. P. Loughran, D. J. Feith
This study evaluates the anti-leukemic effects of LCL-805, an acid ceramidase inhibitor, in AML cell lines and patient samples, showing it promotes iron-dependent cell death by antagonizing Akt signaling.
bioRxiv · Oct 21, 2023Cancer Biology